Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes

Journal of Immunology

Volumn 183, Issue 5, 2009, Pages 3109-3117

  Yasuda, Kei ^a   Richez, Christophe ^a   Uccellini, Melissa B ^a   Richards, Rocco J ^a   Bonegio, Ramon G ^a   Akira, Shizuo ^b   Monestier, Marc ^c   Corley, Ronald B ^a   Viglianti, Gregory A ^a   Marshak Rothstein, Ann ^a   Rifkin, Ian R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DNA FRAGMENT; DOUBLE STRANDED DNA; TOLL LIKE RECEPTOR 9; DNA; IMMUNOLOGICAL ADJUVANT; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CPG ISLAND; DENDRITIC CELL; DNA BINDING MOTIF; DNA METHYLATION; DNA SEQUENCE; DNA STRUCTURE; INTERNALIZATION; LIPOSOMAL GENE DELIVERY SYSTEM; MAMMALIAN GENETICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CHEMISTRY; DNA FRAGMENTATION; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; PSORIASIS; SECRETION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CELLS, CULTURED; CPG ISLANDS; DENDRITIC CELLS; DNA; DNA FRAGMENTATION; DNA METHYLATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PHOSPHOROTHIOATE OLIGONUCLEOTIDES; PSORIASIS; TOLL-LIKE RECEPTOR 9;

EID: 70349260404     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900399     Document Type: Article

References (60)

1. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
2. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
3. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
4. Boule, M. W., C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 1631-1640.
5. Means, T. K., E. Latz, F. Hayashi, M. R. Murali, D. T. Golenbock, and A. D. Luster. 2005. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115: 407-417.
6. Barton, G. M., J. C. Kagan, and R. Medzhitov. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7: 49-56.
7. Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y. H. Wang, B. Homey, W. Cao, Y. H. Wang, B. Su, F. O. Nestle, et al. 2007. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
8. Marshak-Rothstein, A., and I. R. Rifkin. 2007. Immunologically active autoantigens: the role of Toll-like receptors in the development of chronic inflammatory disease. Annu. Rev. Immunol. 25: 419-441.
9. Gilliet, M., W. Cao, and Y. J. Liu. 2008. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat. Rev. Immunol. 8: 594-606.
10. Ahmad-Nejad, P., H. Hacker, M. Rutz, S. Bauer, R. M. Vabulas, and H. Wagner. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32: 1958-1968.
11. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5: 190-198.
12. Bave, U., M. Magnusson, M. L. Eloranta, A. Perers, G. V. Alm, and L. Ronnblom. 2003. FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG. J. Immunol. 171: 3296-3302.
13. Vallin, H., S. Blomberg, G. V. Alm, B. Cederblad, and L. Ronnblom. 1999. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-α (IFN-α) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 115: 196-202.
14. Viglianti, G. A., C. M. Lau, T. M. Hanley, B. A. Miko, M. J. Shlomchik, and A. Marshak-Rothstein. 2003. Activation of autoreactive B cells by CpG dsDNA. Immunity 19: 837-847.
15. Kindrachuk, J., J. Potter, H. L. Wilson, P. Griebel, L. A. Babiuk, and S. Napper. 2008. Activation and regulation of Toll-like receptor 9: CpGs and beyond. Mini Rev. Med. Chem. 8: 590-600.
16. Krieg, A. M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5: 471-484. (Pubitemid 44136959)
17. Muller, T., S. Hamm, and S. Bauer. 2008. TLR9-mediated recognition of DNA. Handb. Exp. Pharmacol. 183: 51-70.
18. Elias, F., J. Flo, R. A. Lopez, J. Zorzopulos, A. Montaner, and J. M. Rodriguez. 2003. Strong cytosine-guanosine-independent immunostimulation in humans and other primates by synthetic oligodeoxynucleotides with PyNTTTTGT motifs. J. Immunol. 171: 3697-3704. (Pubitemid 37254574)
19. Yasuda, K., P. Yu, C. J. Kirschning, B. Schlatter, F. Schmitz, A. Heit, S. Bauer, H. Hochrein, and H. Wagner. 2005. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways. J. Immunol. 174: 6129-6136.
20. Yasuda, K., M. Rutz, B. Schlatter, J. Metzger, P. B. Luppa, F. Schmitz, T. Haas, A. Heit, S. Bauer, and H. Wagner. 2006. CpG motif-independent activation of TLR9 upon endosomal translocation of "natural" phosphodiester DNA. Eur. J. Immunol. 36: 431-436.
21. Haas, T., J. Metzger, F. Schmitz, A. Heit, T. Muller, E. Latz, and H. Wagner. 2008. The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 28: 315-323.
22. Wagner, H. 2008. The sweetness of the DNA backbone drives Toll-like receptor 9. Curr. Opin. Immunol. 20: 396-400.
23. Uccellini, M. B., L. Busconi, N. M. Green, P. Busto, S. R. Christensen, M. J. Shlomchik, A. Marshak-Rothstein, and G. A. Viglianti. 2008. Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-α. J. Immunol. 181: 5875-5884.
24. Ewald, S. E., B. L. Lee, L. Lau, K. E. Wickliffe, G. P. Shi, H. A. Chapman, and G. M. Barton. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658-662.
25. Park, B., M. M. Brinkmann, E. Spooner, C. C. Lee, Y. M. Kim, and H. L. Ploegh. 2008. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9: 1407-1414.
26. Monestier, M., K. E. Novick, and M. J. Losman. 1994. D-penicillamine- and quinidine-induced antinuclear antibodies in A.SW (H-2s) mice: similarities with autoantibodies in spontaneous and heavy metal-induced autoimmunity. Eur. J. Immunol. 24: 723-730. (Pubitemid 24076641)
27. Shi, G. P., J. A. Villadangos, G. Dranoff, C. Small, L. Gu, K. J. Haley, R. Riese, H. L. Ploegh, and H. A. Chapman. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 10: 197-206.
28. Yasuda, K., C. Richez, J. W. Maciaszek, N. Agrawal, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2007. Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J. Immunol. 178: 6876-6885.
29. Krieg, A. M., T. Wu, R. Weeratna, S. M. Efler, L. Love-Homan, L. Yang, A. K. Yi, D. Short, and H. L. Davis. 1998. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. USA 95: 12631-12636.
30. - dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174: 6592-6597.
31. Nur, I., M. Szyf, A. Razin, G. Glaser, S. Rottem, and S. Razin. 1985. Procaryotic and eucaryotic traits of DNA methylation in spiroplasmas (mycoplasmas). J. Bacteriol. 164: 19-24.
32. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, Y. Ohba, and T. Taniguchi. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505.
33. Hornung, V., A. Ablasser, M. Charrel-Dennis, F. Bauernfeind, G. Horvath, D. R. Caffrey, E. Latz, and K. A. Fitzgerald. 2009. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458: 514-518.
34. Fernandes-Alnemri, T., J. W. Yu, P. Datta, J. Wu, and E. S. Alnemri. 2009. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458: 509-513.
35. Roberts, T. L., A. Idris, J. A. Dunn, G. M. Kelly, C. M. Burnton, S. Hodgson, L. L. Hardy, V. Garceau, M. J. Sweet, I. L. Ross, et al. 2009. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323: 1057-1060.
36. Burckstummer, T., C. Baumann, S. Bluml, E. Dixit, G. Durnberger, H. Jahn, M. Planyavsky, M. Bilban, J. Colinge, K. L. Bennett, and G. Superti-Furga. 2009. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat. Immunol. 10: 266-272.
37. Cross, S. H., and A. P. Bird. 1995. CpG islands and genes. Curr. Opin. Genet. Dev. 5: 309-314.
38. Cross, S. H., M. Lee, V. H. Clark, J. M. Craig, A. P. Bird, and W. A. Bickmore. 1997. The chromosomal distribution of CpG islands in the mouse: evidence for genome scrambling in the rodent lineage. Genomics 40: 454-461.
39. Baechler, E. C., P. K. Gregersen, and T. W. Behrens. 2004. The emerging role of interferon in human systemic lupus erythematosus. Curr. Opin. Immunol. 16: 801-807.
40. Theofilopoulos, A. N., R. Baccala, B. Beutler, and D. H. Kono. 2005. Type I interferons (α/β) in immunity and autoimmunity. Annu. Rev. Immunol. 23: 307-336.
41. Banchereau, J., and V. Pascual. 2006. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
42. Vallin, H., A. Perers, G. V. Alm, and L. Ronnblom. 1999. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-α inducer in systemic lupus erythematosus. J. Immunol. 163: 6306-6313.
43. Sano, H., and C. Morimoto. 1982. DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J. Immunol. 128: 1341-1345. (Pubitemid 12188462)
44. Van Helden, P. D. 1985. Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus. J. Immunol. 134: 177-179.
45. Sato, Y., M. Miyata, Y. Sato, T. Nishimaki, H. Kochi, and R. Kasukawa. 1999. CpG motif-containing DNA fragments from sera of patients with systemic lupus erythematosus proliferate mononuclear cells in vitro. J. Rheumatol. 26: 294-301. (Pubitemid 29066731)
46. Krapf, F., M. Herrmann, W. Leitmann, and J. R. Kalden. 1989. Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients. Clin. Exp. Immunol. 75: 336-342.
47. Antequera, F. 2003. Structure, function and evolution of CpG island promoters. Cell. Mol. Life Sci. 60: 1647-1658.
48. Sheriff, A., U. S. Gaipl, R. E. Voll, J. R. Kalden, and M. Herrmann. 2004. Apoptosis and systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 30: 505-527.
49. Sano, H., O. Takai, N. Harata, K. Yoshinaga, I. Kodama-Kamada, and T. Sasaki. 1989. Binding properties of human anti-DNA antibodies to cloned human DNA fragments. Scand. J. Immunol. 30: 51-63.
50. Stollar, B. D., G. Zon, and R. W. Pastor. 1986. A recognition site on synthetic helical oligonucleotides for monoclonal anti-native DNA autoantibody. Proc. Natl. Acad. Sci. USA 83: 4469-4473.
51. Eivazova, E. R., J. M. McDonnell, B. J. Sutton, and N. A. Staines. 2000. Specificity and binding kinetics of murine lupus anti-DNA monoclonal antibodies implicate different stimuli for their production. Immunology 101: 371-377.
52. Vollmer, J., R. D. Weeratna, M. Jurk, U. Samulowitz, M. J. McCluskie, P. Payette, H. L. Davis, C. Schetter, and A. M. Krieg. 2004. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation. Immunology 113: 212-223.
53. Honda, K., Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi. 2005. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434: 1035-1040.
54. Guiducci, C., G. Ott, J. H. Chan, E. Damon, C. Calacsan, T. Matray, K. D. Lee, R. L. Coffman, and F. J. Barrat. 2006. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203: 1999-2008.
55. Zabner, J., A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007.
56. Radler, J. O., I. Koltover, T. Salditt, and C. R. Safinya. 1997. Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275: 810-814.
57. Koltover, I., T. Salditt, J. O. Radler, and C. R. Safinya. 1998. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281: 78-81.
58. Yan, W., W. Chen, and L. Huang. 2007. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines. Mol. Immunol. 44: 3672-3681.
59. Chen, W., J. Wang, H. An, J. Zhou, L. Zhang, and X. Cao. 2005. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-κB signal pathways. Immunol. Lett. 98: 153-159.
60. Hall, J. A., N. Bouladoux, C. M. Sun, E. A. Wohlfert, R. B. Blank, Q. Zhu, M. E. Grigg, J. A. Berzofsky, and Y. Belkaid. 2008. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29: 637-649.